The Current Ratio as of November 2024 (TTM) for ProQR Therapeutics N.V. (PRQR) is 2.73

According to ProQR Therapeutics N.V.’s latest financial reports and current stock price. The company's current Current Ratio is 2.73. This represents a change of -22.33% compared to the average of 3.51 of the last 4 quarters.

ProQR Therapeutics N.V. (PRQR) Historical Current Ratio (quarterly & annually)

How has PRQR Current Ratio performed in the past?

The mean historical Current Ratio of ProQR Therapeutics N.V. over the last ten years is 12.01. The current 2.73 Current Ratio has changed 2.17% with respect to the historical average. Over the past ten years (40 quarters), PRQR's Current Ratio was at its highest in in the September 2014 quarter at 43.99. The Current Ratio was at its lowest in in the June 2024 quarter at 2.73.

ProQR Therapeutics N.V. (PRQR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ProQR Therapeutics N.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ProQR Therapeutics N.V. (PRQR) Average Current Ratio

How has PRQR Current Ratio performed in the past?

The current Current Ratio of ProQR Therapeutics N.V. (PRQR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ProQR Therapeutics N.V. (PRQR) Current Ratio vs. Peers

How is PRQR’s Current Ratio compared to its peers?

ProQR Therapeutics N.V.’s Current Ratio is less than Annexon, Inc. (21.81), less than Arrowhead Pharmaceuticals, Inc. (4.65), less than Day One Biopharmaceuticals, Inc. (14.62), less than Terns Pharmaceuticals, Inc. (21.02), less than Alnylam Pharmaceuticals, Inc. (2.75), greater than Wave Life Sciences Ltd. (0.99), less than Blueprint Medicines Corporation (3.32), less than Apellis Pharmaceuticals, Inc. (5.08), less than Assembly Biosciences, Inc. (2.74), greater than Spero Therapeutics, Inc. (2.68), less than Achilles Therapeutics plc (8.24), less than Instil Bio, Inc. (15.06), less than Neoleukin Therapeutics, Inc. (15.33), greater than CytomX Therapeutics, Inc. (1.00), less than NextCure, Inc. (8.35), less than Nuvation Bio Inc. (11.49),

Build a custom stock screener for ProQR Therapeutics N.V. (PRQR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProQR Therapeutics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ProQR Therapeutics N.V. (PRQR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ProQR Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.